ABEIXI™
生化试剂
| SP-MHCI-0444-2 | HCV virus genotype 1a (isolate H77) Genome polyprotein 2629-2637, KSKKTPMGF |
| SP-MHCI-0444-3 | HCV virus genotype 1a (isolate H77) Genome polyprotein 2629-2637, KSKKTPMGF |
| SP-MHCI-0445-2 | Feline endogenous virus ECE1 Envelope glycoprotein 604-611, KSPWFTTL |
| SP-MHCI-0445-3 | Feline endogenous virus ECE1 Envelope glycoprotein 604-611, KSPWFTTL |
| SP-MHCI-0446-2 | SARS-CoV-2 Nucleoprotein 361-369, KTFPPTEPK |
| SP-MHCI-0446-3 | SARS-CoV-2 Nucleoprotein 361-369, KTFPPTEPK |
| SP-MHCI-0447-2 | Listeria innocua serovar 6a (strain ATCC BAA-680 / CLIP 11262) p60 217-225, KYGVSVQDI |
| SP-MHCI-0447-3 | Listeria innocua serovar 6a (strain ATCC BAA-680 / CLIP 11262) p60 217-225, KYGVSVQDI |
| SP-MHCI-0448-2 | Human RSV Fusion glycoprotein F0 85-93, KYKNAVTEL |
| SP-MHCI-0448-3 | Human RSV Fusion glycoprotein F0 85-93, KYKNAVTEL |
| SP-MHCI-0449-2 | HBV genotype A2 subtype adw (isolate Japan/Nishioka/1983) Protein P 751-758, KYTSFPWLL |
| SP-MHCI-0449-3 | HBV genotype A2 subtype adw (isolate Japan/Nishioka/1983) Protein P 751-758, KYTSFPWLL |
| SP-MHCI-0450-2 | HCV virus genotype 1a (isolate H77) Genome polyprotein 654-662, LEDRDRSEL |
| SP-MHCI-0450-3 | HCV virus genotype 1a (isolate H77) Genome polyprotein 654-662, LEDRDRSEL |
| SP-MHCI-0451-2 | EBV EBNA3 406-414, LEKARGSTY |
| SP-MHCI-0451-3 | EBV EBNA3 406-414, LEKARGSTY |
| SP-MHCI-0452-2 | M. tuberculosis Alpha-crystallin 21-40, LFAAFPSFAGLRPTFDTRLM |
| SP-MHCI-0452-3 | M. tuberculosis Alpha-crystallin 21-40, LFAAFPSFAGLRPTFDTRLM |
| SP-MHCI-0453-2 | Triticum aestivum Alpha/beta-gliadin 51-62, LGQQQPFPPQQPY |
| SP-MHCI-0453-3 | Triticum aestivum Alpha/beta-gliadin 51-62, LGQQQPFPPQQPY |
| SP-MHCI-0454-2 | YFV Genome polyprotein 746-760, LIWVGINTRNMTMSM |
| SP-MHCI-0454-3 | YFV Genome polyprotein 746-760, LIWVGINTRNMTMSM |
| SP-MHCI-0455-2 | HCV virus genotype 1a (isolate H77) Genome polyprotein 178-187, LLALLSCLTV |
| SP-MHCI-0455-3 | HCV virus genotype 1a (isolate H77) Genome polyprotein 178-187, LLALLSCLTV |
| SP-MHCI-0456-2 | HBV genotype A2 subtype adw (isolate Japan/Nishioka/1983) Protein P 520-527, LLAQFTSAI |
| SP-MHCI-0456-3 | HBV genotype A2 subtype adw (isolate Japan/Nishioka/1983) Protein P 520-527, LLAQFTSAI |
| SP-MHCI-0457-2 | HCV virus genotype 1a (isolate H77) Genome polyprotein 1169-1177, LLCPAGHAV |
| SP-MHCI-0457-3 | HCV virus genotype 1a (isolate H77) Genome polyprotein 1169-1177, LLCPAGHAV |
| SP-MHCI-0458-2 | M. tuberculosis (strain ATCC 25618 / H37Rv) 6 kDa early secretory antigenic target 28-36, LLDEGKQSL |
| SP-MHCI-0458-3 | M. tuberculosis (strain ATCC 25618 / H37Rv) 6 kDa early secretory antigenic target 28-36, LLDEGKQSL |
| SP-MHCI-0459-2 | M. tuberculosis (strain ATCC 25618 / H37Rv) EttA 182-190, LLDEPTNHL |
| SP-MHCI-0459-3 | M. tuberculosis (strain ATCC 25618 / H37Rv) EttA 182-190, LLDEPTNHL |
| SP-MHCI-0460-2 | Human Gamma-interferon-inducible lysosomal thiol reductase 16-24, LLDVPTAAV |
| SP-MHCI-0460-3 | Human Gamma-interferon-inducible lysosomal thiol reductase 16-24, LLDVPTAAV |
| SP-MHCI-0461-2 | NY-ESO 1 87-111, LLEFYLAMPFATPMEAELARRSLAQ |
| SP-MHCI-0461-3 | NY-ESO 1 87-111, LLEFYLAMPFATPMEAELARRSLAQ |
| SP-MHCI-0462-2 | HCV virus genotype 1a (isolate H77) Genome polyprotein 1807-1816, LLFNILGGWV |
| SP-MHCI-0462-3 | HCV virus genotype 1a (isolate H77) Genome polyprotein 1807-1816, LLFNILGGWV |
| SP-MHCI-0463-2 | SARS-CoV-2 Spike 821-829, LLFNKVTLA |
| SP-MHCI-0463-3 | SARS-CoV-2 Spike 821-829, LLFNKVTLA |
| SP-MHCI-0464-2 | BKV Large T antigen 579-587, LLLIWFRPV |
| SP-MHCI-0464-3 | BKV Large T antigen 579-587, LLLIWFRPV |
| SP-MHCI-0465-2 | Human papillomavirus type 16 Protein E7 82-90, LLMGTLGIV |
| SP-MHCI-0465-3 | Human papillomavirus type 16 Protein E7 82-90, LLMGTLGIV |
| SP-MHCI-0466-2 | BKV Major capsid protein VP1 108-116, LLMWEAVTV |
| SP-MHCI-0466-3 | BKV Major capsid protein VP1 108-116, LLMWEAVTV |
| SP-MHCI-0467-2 | HCV virus genotype 1a (isolate H77) Genome polyprotein 36-44, LLPRRGPRL |
| SP-MHCI-0467-3 | HCV virus genotype 1a (isolate H77) Genome polyprotein 36-44, LLPRRGPRL |
| SP-MHCI-0468-2 | Human Vimentin 79-88, LLQDSVDFSL |
| SP-MHCI-0468-3 | Human Vimentin 79-88, LLQDSVDFSL |
| SP-MHCI-0469-2 | Influenza A (strain A/Chicken/Weybridge H7N7) Matrix protein 1 3-11, LLTEVETYV |
| SP-MHCI-0469-3 | Influenza A (strain A/Chicken/Weybridge H7N7) Matrix protein 1 3-11, LLTEVETYV |
| SP-MHCI-0470-2 | EBV Latent membrane protein 2 329-337, LLWTLVVLL |
| SP-MHCI-0470-3 | EBV Latent membrane protein 2 329-337, LLWTLVVLL |
| SP-MHCI-0471-2 | Survivin (BIRC5) (BIRC5) 96-104, LMLGEFLKL |
| SP-MHCI-0471-3 | Survivin (BIRC5) (BIRC5) 96-104, LMLGEFLKL |
| SP-MHCI-0472-2 | Human CMV pp65 320-328, LMNGQQIFL |
| SP-MHCI-0472-3 | Human CMV pp65 320-328, LMNGQQIFL |
| SP-MHCI-0473-2 | HHV 8 type P (isolate GK18) Envelope glycoprotein B 487-494, LMWYELSKI |
| SP-MHCI-0473-3 | HHV 8 type P (isolate GK18) Envelope glycoprotein B 487-494, LMWYELSKI |
| SP-MHCI-0474-2 | EBV Lytic switch protein BZLF1 44-52, LPCVLWPVL |
| SP-MHCI-0474-3 | EBV Lytic switch protein BZLF1 44-52, LPCVLWPVL |
| SP-MHCI-0475-2 | EBV Lytic switch protein BZLF1 52-64, LPEPLPQGQLTAY |
| SP-MHCI-0475-3 | EBV Lytic switch protein BZLF1 52-64, LPEPLPQGQLTAY |
| SP-MHCI-0476-2 | Influenza A (strain A/Puerto Rico/8/1934 H1N1) Nucleoprotein 418-426, LPFDKPTIM |
| SP-MHCI-0476-3 | Influenza A (strain A/Puerto Rico/8/1934 H1N1) Nucleoprotein 418-426, LPFDKPTIM |
| SP-MHCI-0477-2 | Influenza A (strain A/Puerto Rico/8/1934 H1N1) Nucleoprotein 418-426, LPFDKSTIM |
| SP-MHCI-0477-3 | Influenza A (strain A/Puerto Rico/8/1934 H1N1) Nucleoprotein 418-426, LPFDKSTIM |
| SP-MHCI-0478-2 | Influenza A (strain A/Puerto Rico/8/1934 H1N1) Nucleoprotein 418-426, LPFEKSTVM |
| SP-MHCI-0478-3 | Influenza A (strain A/Puerto Rico/8/1934 H1N1) Nucleoprotein 418-426, LPFEKSTVM |
| SP-MHCI-0479-2 | Influenza A (strain A/Puerto Rico/8/1934 H1N1) Nucleoprotein 418-426, LPFERATIM |
| SP-MHCI-0479-3 | Influenza A (strain A/Puerto Rico/8/1934 H1N1) Nucleoprotein 418-426, LPFERATIM |
| SP-MHCI-0480-2 | HCV virus genotype 1a (isolate H77) Genome polyprotein 169-177, LPGCSFSIF |
| SP-MHCI-0480-3 | HCV virus genotype 1a (isolate H77) Genome polyprotein 169-177, LPGCSFSIF |
| SP-MHCI-0481-2 | Human CMV pp65 116-129, LPLKMLNIPSINVH |
| SP-MHCI-0481-3 | Human CMV pp65 116-129, LPLKMLNIPSINVH |
| SP-MHCI-0482-2 | HBV genotype A2 subtype adw (isolate Japan/Nishioka/1983) Capsid protein 19-27, LPSDFFPSV |
| SP-MHCI-0482-3 | HBV genotype A2 subtype adw (isolate Japan/Nishioka/1983) Capsid protein 19-27, LPSDFFPSV |
| SP-MHCI-0483-2 | Human Isoform 2 of Tyrosinase 208-216, LPWHRLFLL |
| SP-MHCI-0483-3 | Human Isoform 2 of Tyrosinase 208-216, LPWHRLFLL |
| SP-MHCI-0484-2 | M. tuberculosis (strain ATCC 25177 / H37Ra) Ag85A 51-70, LQVPSPSMGRDIKVQFQSGG |
| SP-MHCI-0484-3 | M. tuberculosis (strain ATCC 25177 / H37Ra) Ag85A 51-70, LQVPSPSMGRDIKVQFQSGG |
| SP-MHCI-0485-2 | EBV EBNA6 249-258, LRGKWQRRYR |
| SP-MHCI-0485-3 | EBV EBNA6 249-258, LRGKWQRRYR |
| SP-MHCI-0486-2 | EBV EBNA1 536-544, LSRLPFGMA |
| SP-MHCI-0486-3 | EBV EBNA1 536-544, LSRLPFGMA |
| SP-MHCI-0487-2 | EBV Latent membrane protein 2 453-461, LTAGFLIFL |
| SP-MHCI-0487-3 | EBV Latent membrane protein 2 453-461, LTAGFLIFL |
| SP-MHCI-0488-2 | HBV genotype C subtype ayr (isolate Human/Japan/Okamoto/- Protein P 388-397, LVVDFSQFSR |
| SP-MHCI-0488-3 | HBV genotype C subtype ayr (isolate Human/Japan/Okamoto/- Protein P 388-397, LVVDFSQFSR |
| SP-MHCI-0489-2 | HBV genotype C subtype ar (isolate Japan/S-207/1988) Capsid protein 93-100, MGLKFRQL |
| SP-MHCI-0489-3 | HBV genotype C subtype ar (isolate Japan/S-207/1988) Capsid protein 93-100, MGLKFRQL |
| SP-MHCI-0490-2 | Human papillomavirus type 16 Protein E7 12-20, MLDLQPETT |
| SP-MHCI-0490-3 | Human papillomavirus type 16 Protein E7 12-20, MLDLQPETT |
| SP-MHCI-0491-2 | Human Melanocyte protein PMEL 178-186, MLGTHTMEV |
| SP-MHCI-0491-3 | Human Melanocyte protein PMEL 178-186, MLGTHTMEV |
| SP-MHCI-0492-2 | Human Isoform 2 of Tyrosinase 1-9, MLLAVLYCL |
| SP-MHCI-0492-3 | Human Isoform 2 of Tyrosinase 1-9, MLLAVLYCL |
| SP-MHCI-0493-2 | Human CMV pp65 120-128, MLNIPSINV |
| SP-MHCI-0493-3 | Human CMV pp65 120-128, MLNIPSINV |